D46.B

D46.B: Refractory cytopenia with multilineage dysplasia and ring sideroblasts

Billable / specific codeICD-10-CM

D46.B is a billable, specific ICD-10-CM code for refractory cytopenia with multilineage dysplasia and ring sideroblasts. It is valid for submission on a claim.

Check D46.B with the rest of the claim: free scrubber

Inclusion terms

Alternative wordings a physician may use in the chart for this same code.

RCMD RS

Excludes2 inherited from the categories above D46.B

Not part of this code, but both may be coded when both are present.

Written on D46: Myelodysplastic syndromes

drug-induced aplastic anemia (D61.1)

Other codes that can never be billed with D46.B

Their own Excludes1 notes name this code, so the conflict is not listed above.

C94Other leukemias of specified cell type
D64Other anemias

Risk adjustment

D46.B risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

HCC 19 Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers1.798 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.

Medicare coverage

D46.B is named in 45 Medicare coverage policies: 45 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

A52479Oral Anticancer Drugs - Policy Article
A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
A52986Billing and Coding: Biomarkers for Oncology
A55717Billing and Coding: Lab: Flow Cytometry

Alphabetic index entries that lead here

Cytopenia›refractory›with multilineage dysplasia›and ring sideroblasts(RCMD RS)
Syndrome›myelodysplastic›with›multilineage dysplasia›with ringed sideroblasts

Code history

Unchanged in every release from FY2024 to FY2027.